Morbidity and mortality in schizophrenia with comorbid substance use disorders

Morbidity and mortality in schizophrenia with comorbid substance use disorders

Schizophrenia is highly comorbid with substance use disorders (SUD) but large epidemiological cohorts exploring the prevalence and prognostic significance of SUD are lacking. Here, we investigated the prevalence of SUD in patients with schizophrenia in Finland and Sweden, and the effect of these co-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta psychiatrica Scandinavica 2021-07, Vol.144 (1), p.42-49
Hauptverfasser: Lähteenvuo, Markku, Batalla, Albert, Luykx, Jurjen J, Mittendorfer-Rutz, Ellenor, Tanskanen, Antti, Tiihonen, Jari, Taipale, Heidi
Format: Artikel
Sprache:eng
Schlagworte:
Original
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Schizophrenia is highly comorbid with substance use disorders (SUD) but large epidemiological cohorts exploring the prevalence and prognostic significance of SUD are lacking. Here, we investigated the prevalence of SUD in patients with schizophrenia in Finland and Sweden, and the effect of these co-occurring disorders on risks of psychiatric hospitalization and mortality. 45,476 individuals with schizophrenia from two independent national cohort studies, aged
ISSN:0001-690X
1600-0447
DOI:10.1111/acps.13291